The FDA has approved a new treatment option that is the first drug approved by the FDA specifically for the treatment of postpartum depression in adult women.
The FDA has proposed that restrictions on flavored electronic cigarettes be tightened, in response to recent data showing a dramatic increase in the use of electronic nicotine delivery system (ENDS) use...
After last year’s recall of valsartan tablets, the FDA has prioritized the approval of a new generic form of the angiotensin II receptor blocker to address the drug shortage.
The FDA issued an alert regarding the safety of tofacitinib following the results of a clinical trial that showed increased risk of pulmonary embolism.
The FDA has called for the addition of a Boxed Warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a drug used for the treatment of gout.
The FDA has called for the addition of a Boxed Warning alerting clinicians and patients of an increased risk of cardiovascular death with the use of a drug used for the treatment of gout.
The FDA has issued new proposed regulations for over-the-counter sunscreens marketed in the United States updating regulatory requirements to ensure consumers have access to safe and effective sun...
The FDA Psychopharmacologic Drug Advisory Committee and Drug Safety and Risk Management Advisory Committee jointly voted on the benefit-risk profile of esketamine nasal spray for the treatment of adults...
The FDA has approved the first therapy specifically indicated (in combination with plasma exchange and immunosuppressive therapy) for the treatment of adults with acquired thrombotic thrombocytopenic...
